|
1.
|
原著
|
Complete Remission After Percutaneous Renal Artery Angioplasty for Focal Segmental Glomerulosclerosis due to Takayasu Disease: A Case Report. 2026/03
|
|
2.
|
原著
|
Association of anemia with long-term renal prognosis in autosomal dominant polycystic kidney disease using time-series analysis. 2026/02/27
|
|
3.
|
原著
|
Middle cerebral artery aneurysms in older women with autosomal dominant polycystic kidney disease. 2025/10/30
|
|
4.
|
原著
|
Attribute-Based Medicine for IgAN: A Nationwide Japanese Cohort Reveals Prognostic Interactions 2025/10
|
|
5.
|
原著
|
Challenges in the Histopathologic Diagnosis of Autosomal Dominant Alport Syndrome: A Comparative Genotype-Based Study 2025/10
|
|
6.
|
原著
|
Disease-Specific Prevalence and Clinical Significance of Antinephrin Autoantibodies in Adult Japanese Patients with Podocytopathy: A Single-Center Cohort Study, 2016-2024 2025/10
|
|
7.
|
原著
|
Granulomatous Interstitial Nephritis Suspected to Be Caused by Adverse Reaction to Metal Debris: A Case Report 2025/10
|
|
8.
|
原著
|
High-Pulse Pressure and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
9.
|
原著
|
Hypertriglyceridemia and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
10.
|
原著
|
Hyperuricemia and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
11.
|
原著
|
Increased Risk of Middle Cerebral Artery Aneurysms in Postmenopausal Women with ADPKD: Insights from Attribute-Based Medicine (ABM) with Cross-Classification Based on Sex and Age 2025/10
|
|
12.
|
原著
|
Overweight/Obesity and Kidney Prognosis in ADPKD: Insights from Attribute-Based Cross-Classification by Sex and Age 2025/10
|
|
13.
|
原著
|
Sacubitril Valsartan and Prevention of Initial Dip Induced by SGLT2 Inhibitors 2025/10
|
|
14.
|
原著
|
腎生検所見から何を学ぶか 東京腎生検カンファランス(No.68) Adverse reaction to metal debrisによる肉芽腫性間質性腎炎が疑われる1例 2025/10
|
|
15.
|
原著
|
ATTR wildtypeアミロイドーシスに併発した分節性NELL-1陽性膜性腎症の一例 2025/09/10
|
|
16.
|
原著
|
CKD合併妊娠から周産期心筋症を呈し,遺伝子検査でミトコンドリア病と診断され末期腎不全に至った一例 2025/09/10
|
|
17.
|
原著
|
MPO-ANCA陽性のIgA腎症へ治療介入後に腎炎が再燃しANCA関連血管炎と診断した一例 2025/09/10
|
|
18.
|
原著
|
経時的に増大した腎腫瘤を契機に腎サルコイドーシスの診断に至った透析患者の一例 2025/09/10
|
|
19.
|
原著
|
血尿・糸球体腎炎を認めず,腎機能障害を契機に診断されたANCA関連血管炎(AVV)の2例 2025/09/10
|
|
20.
|
原著
|
高安病による腎動脈狭窄により呈したネフローゼ症候群にPTRAを施行し寛解導入となった一例 2025/09/10
|
|
21.
|
原著
|
生検後長期間経過したのち再生検となったAlport症候群の2例 2025/09/10
|
|
22.
|
原著
|
双胎妊娠中にIgA腎症によるネフローゼ症候群を発症し,集学的治療により良好な転帰を得た一例 2025/09/10
|
|
23.
|
原著
|
両腎の多発微小嚢胞からADPKD-DNAJB11と診断した一家系 2025/09/10
|
|
24.
|
原著
|
Attribute-Based Medicine for IgA Nephropathy: Risk Factor Constellations Influence Kidney Prognosis. 2025/08/27
|
|
25.
|
原著
|
ADPKD患者における腎予後に関する性差 属性に基づく医療(ABM)の視点より 2025/06/04
|
|
26.
|
原著
|
ARNIによるSGLT2阻害薬のinitial dip抑制効果の検討 2025/06/04
|
|
27.
|
原著
|
SLE患者におけるヒドロキシクロロキン使用に伴うゼブラボディ/ミエロイドボディ出現の検討 2025/06/04
|
|
28.
|
原著
|
Brevibacterium speciesによるPD腹膜炎の1例 2025/06
|
|
29.
|
原著
|
トシリズマブ投与中のPD患者に発症した急性虫垂炎の1例 2025/06
|
|
30.
|
原著
|
透析導入8年後にARNI導入によって心機能が改善し腎移植が可能となった1例 2025/06
|
|
31.
|
原著
|
Overexpression of plasmalemmal vesicle-associated protein-1 in patient with cyanotic nephropathy: a case report. 2025/03
|
|
32.
|
原著
|
常染色体顕性(優性)多発性嚢胞腎におけるSplicing mutationと脳動脈瘤発症の関連性について 2025/03
|
|
33.
|
原著
|
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. 2025/01
|
|
34.
|
原著
|
Urinary casts containing crystals in light chain proximal tubulopathy. 2024/11
|
|
35.
|
原著
|
腎生検所見から何を学ぶか(No.67) 急激な腎機能障害,心機能障害を呈しcrystalglobulin-induced nephrologyが疑われた1例 2024/10/25
|
|
36.
|
原著
|
Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP) 2024/10
|
|
37.
|
症例報告
|
30年の長期寛解後に再発したC3腎炎の一例 2024/09/10
|
|
38.
|
原著
|
リツキシマブを使用した膜性腎症 2024/09/10
|
|
39.
|
症例報告
|
感染後糸球体腎炎(PIGN)を発症した腎移植ドナーの2症例 2024/09/10
|
|
40.
|
症例報告
|
血管炎を呈した薬剤性尿細管間質性腎炎の1例 2024/09/10
|
|
41.
|
症例報告
|
高安動脈炎,腎動脈狭窄によるFSGSに経皮的腎動脈形成術(PTRA)が著効した一例 2024/09/10
|
|
42.
|
症例報告
|
腎生検でIgG-κ産生B細胞性リンパ腫を診断したCrystal storing histiocytosis(CSH)の一例 2024/09/10
|
|
43.
|
症例報告
|
致死的な経過をたどったCrystalglobulin-induced nephropathyの一例 2024/09/10
|
|
44.
|
症例報告
|
長期関節リウマチ患者に発症したNELL-1陽性の抗DNA抗体陰性ループス腎炎の1例 2024/09/10
|
|
45.
|
症例報告
|
尿沈渣が診断に有用であったLight chain proximal tubulopathy(LCPT)の3例 2024/09/10
|
|
46.
|
原著
|
IgA腎症における属性医療(ABM)～性差,年齢,BMI,CKD-stageの腎予後因子への影響について 2024/06/15
|
|
47.
|
原著
|
常染色体顕性多発性嚢胞腎における脳動脈瘤と脳出血の有病率と特徴 2024/06/15
|
|
48.
|
原著
|
ADPKD患者の脳動脈瘤に関する性差について 2024/06
|
|
49.
|
原著
|
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD 2024/05/31
|
|
50.
|
症例報告
|
胆管交通性感染肝嚢胞に対して胆管バルーン併用硬化療法で感染制御，瘻孔閉鎖できた一例 2024/05/28
|
|
51.
|
原著
|
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. 2024/05
|
|
52.
|
原著
|
常染色体顕性(優性)多発性嚢胞腎におけるSplicing mutationと脳動脈瘤発症の関連性について 2024/03
|
|
53.
|
原著
|
PLA2R-positive membranous nephropathy in IgG4-related disease 2024/02/23
|
|
54.
|
原著
|
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
|
|
55.
|
原著
|
Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
|
|
56.
|
総説
|
HIF-PH阻害薬の網膜への影響 2023/05
|
|
57.
|
原著
|
機械学習を用いたADPKDにおける脳動脈瘤発症関連因子の検討 2023/05
|
|
58.
|
原著
|
急激な腎機能増悪により腎代替療法を要した軽鎖重鎖沈着症の一例 2023/05
|
|
59.
|
原著
|
Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study. 2023/03
|
|
60.
|
原著
|
Machine learning for morbid glomerular hypertrophy. 2022/11
|
|
61.
|
総説
|
透析患者の薬,どう使いわける? 糖尿病治療薬 2022/11
|
|
62.
|
原著
|
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2022/10/27
|
|
63.
|
総説
|
【多発性嚢胞腎（ADPKD)の合併症とその治療】脳動脈瘤 2022/10/25
|
|
64.
|
原著
|
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. 2022/06
|
|
65.
|
原著
|
First case of a renal cyst infection caused by Desulfovibrio: a case report and literature reviw 2022/05/23
|
|
66.
|
原著
|
Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
|
|
67.
|
原著
|
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
|
|
68.
|
原著
|
Germline Mutations for Kidney Volume in ADPKD 2021/12/13
|
|
69.
|
総説
|
ADPKD 3）遺伝子診断：診断と予後 2021/11
|
|
70.
|
原著
|
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
|
|
71.
|
原著
|
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
|
|
72.
|
原著
|
Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2021/05/01
|
|
73.
|
原著
|
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
|
|
74.
|
原著
|
Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
|
|
75.
|
原著
|
Sex Differences in Time-Series Changes in Pseudo-R² Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
|
|
76.
|
原著
|
Visceral to subcutaneous fat ratio as an indicator of a ≧30％ eGFR decline in chronic kidney disease 2020/11
|
|
77.
|
原著
|
Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study. 2020/05/07
|
|
78.
|
原著
|
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
|
|
79.
|
原著
|
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
|
|
80.
|
原著
|
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
|
|
81.
|
原著
|
Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
|
|
5件表示
|
|
全件表示(81件)
|
